ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Ra Medical Systems Inc

Ra Medical Systems Inc (RMED)

8.82
0.00
(0.00%)
Closed September 19 4:00PM
8.82
0.00
( 0.00% )
Pre Market: 8:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
8.82
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
8.82
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
7,027,000
Dividend Yield
-
PE Ratio
-0.88
Earnings Per Share (EPS)
-10.04
Revenue
442k
Net Profit
-70.57M

About Ra Medical Systems Inc

Ra Medical Systems Inc is a commercial-stage medical device company leveraging its laser-based platform for use in the treatment of vascular diseases. Its products restore blood-flow in arteries and clearing chronic skin conditions. The firm's products include DABRA and Pharos. DABRA System is used ... Ra Medical Systems Inc is a commercial-stage medical device company leveraging its laser-based platform for use in the treatment of vascular diseases. Its products restore blood-flow in arteries and clearing chronic skin conditions. The firm's products include DABRA and Pharos. DABRA System is used as a tool in the treatment of peripheral artery disease, or PAD, a form of peripheral vascular disease, which commonly occurs in the legs. Pharos is designed for use in the treatment of inflammatory skin conditions and as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
-

RMED Latest News

Ra Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association Congress

Four abstracts with clinical data supporting use of Catheter Precision’s VIVO™ technology accepted for presentation at leading electrophysiology conference Ra Medical Systems, Inc. (NYSE...

Ra Medical Systems Realigns Its Board of Directors

Ra Medical Systems (NYSE American: RMED) announces a realignment of its board of directors in conjunction with the recently announced merger with Catheter Precision, Inc. David Jenkins has joined...

Ra Medical Systems Completes Merger with Catheter Precision

Medtech Veteran and Catheter Precision CEO and Founder David Jenkins to Serve as Executive Chairman Enters Agreements to Raise up to $9.3 Million in Equity Ra Medical Systems, Inc. (NYSE...

Ra Medical Systems Regains Compliance with NYSE American Continued Listing Standards

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces that it has received notification from the NYSE American LLC (“NYSE American”) that the Company has...

Catheter Precision’s VIVO™ System Used in More Than 800 Procedures in Leading U.S. and European Hospitals

Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces that more than 800 procedures have been performed in a number of leading U.S. and...

Catheter Precision’s VIVO™ Systems Used in More Than 20 Procedures at NYU Langone Hospital

Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces the completion of more than 20 procedures at NYU Langone Hospital utilizing the...

Ra Medical Systems Reports Third Quarter 2022 Financial Results

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) reports financial results for the three and nine months ended September 30, 2022 and provides a business update. On...

Catheter Precision Expands U.S. Customer Base for VIVO™ for Non-invasive Arrythmia Location Detection Before Ventricular Ablation Procedures

Catheter Precision, Inc. (“Catheter Precision”), a medical device company focused on cardiac electrophysiology, announces receipt of three commercial orders in the past 60 days as usage of the...

Ra Medical Systems Raises $7.6 Million Through Completed At-The-Market Facility

Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces the completion of its at-the-market (ATM) facility, raising gross proceeds of $7.6 million. The Company...

Catheter Precision Files a Method-of-Use U.S. Patent Application for its VIVO™ Technology

Catheter Precision, Inc. (“Catheter Precision”), a medical device company focused on cardiac electrophysiology, announces the filing of a new U.S. patent application for its VIVO™ (View Into...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SRFMSurf Air Mobility Inc
$ 1.24
(9.73%)
1.08k
OKLOOklo Inc
$ 7.2389
(9.51%)
192.85k
AMPXAmprius Technologies Inc
$ 0.9454
(8.06%)
2.87k
NKENike Inc
$ 87.20
(7.68%)
843.94k
LEN.BLennar Corp
$ 189.59
(7.33%)
3
FDXFedEx Corp
$ 259.50
(-13.61%)
312.58k
BFAMBright Horizons Family Solutions Inc
$ 121.50
(-10.99%)
45
FAMFirst Trust abrdn Global Opportunity Income Fund
$ 6.01
(-8.66%)
2
SOCSable Offshore Corp
$ 26.10
(-7.77%)
8.59k
BNEDBarnes and Noble Education Inc
$ 10.65
(-5.84%)
3.78k
PLTRPalantir Technologies Inc
$ 36.08
(-2.04%)
1.83M
NKENike Inc
$ 87.20
(7.68%)
843.94k
NIONIO Inc
$ 5.37
(-0.56%)
769.53k
CHWYChewy Inc
$ 30.14
(-3.09%)
375.71k
SMRNuScale Power Corporation
$ 9.94
(3.43%)
329.73k

Discussion

View Full Feed
TradingCharts TradingCharts 3 minutes ago
Much better sales team than ibat and smart enough to fill out paperwork for loans and grants. IBAT has no brines their biggest downfall.

You watch E3 will get grant soon. E3 will receive more than 2% royalties better play in the long run than ibat. Also E3 can sell the brines anytime
ETL
EnigmaticKraken98 EnigmaticKraken98 3 minutes ago
My thought on BLMZ

With BloomZ making strides in innovative projects and expanding into new markets, it seems well-positioned to reach the $35 million Nasdaq market cap requirement. The company’s recent developments have caught the attention of investors who are optimistic about its g
BLMZ
Wayne R Wayne R 3 minutes ago
Ask yourself, why Delaware
AGBA
Welcome2Pinkyland Welcome2Pinkyland 3 minutes ago
Whinny R - you seem to be self aware- at least in admitting to being a no one.
JettaR JettaR 4 minutes ago
All of which is generating how much in revenues?? Enough to pay for all the promotions?
CBDW
NYCPuglet NYCPuglet 4 minutes ago
Devin Nunes understands social media.
DJT
Gmenfan Gmenfan 4 minutes ago
Not far fetched!!!
Backstabbed Backstabbed 4 minutes ago
Good morning everyone! $ZHUD’sters!
ZHUD
The Whale The Whale 5 minutes ago
Is that all you got....please put your pic up so we can see you huge nose...🤣🤣🤣
Debunkinator Debunkinator 5 minutes ago
The $ASII pot is boiling $$$
$ASII had a great call with NASDAQ Nordic Specialist today!
HUGE UPDATE NEXT, we’re just getting started
#UPLIST #NORDIC
9:48 AM · Sep 19, 2024
·
2,308
Views
ASII
tradernewstip tradernewstip 5 minutes ago
Can Adnexus do the blood pressure test results :)
CBDW
J2003 J2003 5 minutes ago
Knos looks good isn’t it?
KNOS
jedijazz jedijazz 5 minutes ago
$AGBA GROUP UPDATE:
•AGBA's merger with Triller Corp. is on track to close

•Shareholder approval was granted for AGBA to be incorporated as a Delaware Corporation and domiciled in the U.S., operating under the name Triller Group Inc.

•All AGBA/Triller merger clos
AGBA
Viking61 Viking61 6 minutes ago
Just finished off a Skyline chili cheese dog with onion and mustard at 8:20 am😃 GLTA!!
FNMA
Yo-Yo Yo-Yo 6 minutes ago
Excellent!!!! Call!!! v!!!!
hotdawg hotdawg 6 minutes ago
Don't let him get to you he will go away as soon as he finds another stock to complain about.
CONY
oldstocks oldstocks 6 minutes ago
TJ i have been in some cemeteries and they have been noisier than Jim

Quite Frankly i think i heard Frankenstein and Dracula in one graveyard talking about Jim and AFFU while the bats 🦇 where flying around
AFFU
SkyLimit2022 SkyLimit2022 6 minutes ago
NotSure2,

Thanks for asking!

Yes! Absolutely! The benefits, both realized and potential for each patient, are notably high and significant for the most challenging cancers to treat and survive—newly diagnosed GBM (nGBM) and recurrent GBM (rGBM). The JAMA study highligh
NWBO
ANTI-BAGHOLDER ANTI-BAGHOLDER 6 minutes ago
I never said it wasn’t. You said you have never seen such a small float in trips…

Which is obviously very wrong. So I pointed you to one.

ZMRK
TechandBio TechandBio 7 minutes ago
In at $7.00 Holding for $150.00

VKTX
VKTX
KeepItRealistic KeepItRealistic 7 minutes ago
$GNS is a NO 🧠’er buy and hold for a FAIR MARKET VALUE

$105m revenue 2024

Current Market Cap 19m

The revenue multiple, is a valuation metric used to estimate the value of a company based on its revenue.

In the education market, det
GNS
KeepItRealistic KeepItRealistic 7 minutes ago
$GNS is a NO 🧠’er buy and hold for a FAIR MARKET VALUE

$105m revenue 2024

Current Market Cap 19m

The revenue multiple, is a valuation metric used to estimate the value of a company based on its revenue.

In the education market, det
GNS
TheKid5 TheKid5 7 minutes ago
newsday
CLNV
jedijazz jedijazz 7 minutes ago
$CVKD - Zacks initiating coverage of Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) with a $30.00 valuation. Cadrenal is a biopharmaceutical developing innovative therapies for life-threatening cardiovascular and renal diseases. https://scr.zacks.com/news/news-details/2024/CVKD-New-Blood-Thinner-Ready-f
CVKD

Your Recent History

Delayed Upgrade Clock